Blackrock, INC Schedule 13G passive stakes

NYSE
BlackRock Inc. has reported a 4.2% beneficial ownership in Candel Therapeutics Inc. as of March 31, 2026, holding over 3 million shares.
NYSE
BlackRock, Inc. has reported beneficial ownership of 5.1% of Dianthus Therapeutics Inc.'s common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.0% of First Mid Bancshares, Inc. common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing beneficial ownership of 939,393 shares, representing 6.5% of the outstanding common stock of the iShares J.P. Morgan EM High Yield Bond ETF.
NYSE
BlackRock, Inc. has disclosed a beneficial ownership of 5.6% in LSB Industries Inc. as of March 31, 2026.
NYSE
BlackRock, Inc. has disclosed beneficial ownership of 804,944 shares, representing 6.5% of the outstanding common stock of Metropolitan Bank Holding Corp.
NYSE
BlackRock Inc. has disclosed a beneficial ownership of 5.7% in Mirum Pharmaceuticals, Inc. as of March 31, 2026.
NYSE
BlackRock, Inc. has reported beneficial ownership of 5.4% of Credicorp Ltd.'s common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 4.9% of Golar LNG Limited's common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has reported beneficial ownership of 5.2% of Nutrien Ltd.'s common stock as of March 31, 2026, holding over 24.8 million shares.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6,814,525 shares, representing 4.8% of the outstanding common stock of Niocorp Developments Ltd.
NYSE
BlackRock, Inc. has disclosed beneficial ownership of 3,218,304 shares, representing 5.3% of the outstanding common stock of NICE LTD, as of March 31, 2026.
NYSE
BlackRock, Inc. has reported beneficial ownership of 5.2% of Urogen Pharma Ltd's common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 4.96% of Caledonia Mining Corporation PLC's common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has reported a beneficial ownership of 5.8% in Greenlight Capital Re Ltd's Class A Stock as of March 31, 2026.
NYSE
BlackRock Inc. has disclosed a beneficial ownership of 8.0% of ADT Inc.'s common stock as of March 31, 2026, holding over 60.9 million shares.
NYSE
BlackRock, Inc. has filed a Schedule 13G amendment, reporting zero beneficial ownership of common stock in Advanced Flower Capital Inc. as of March 31, 2026.
NYSE
BlackRock, Inc. has updated its Schedule 13G filing, reporting beneficial ownership of 570,866 shares, representing 0.4% of the outstanding common stock of Apartment Investment and Management Co. as of March 31, 2026.
NYSE
BlackRock, Inc. has reported beneficial ownership of 5.03% of BioAge Labs, Inc.'s common stock as of March 31, 2026.
NYSE
BlackRock Inc. has disclosed a beneficial ownership of 4.8% in Bumble Inc.'s Class A Stock as of March 31, 2026, holding over 6.2 million shares.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing beneficial ownership of 4.98% of CB Financial Services Inc.'s common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has reported beneficial ownership of 9.3% of Dutch Bros Inc.'s Class A Stock as of March 31, 2026.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7.7% of Dynex Capital Inc.'s common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has reported beneficial ownership of 5.8% of Eledon Pharmaceuticals, Inc.'s common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has disclosed beneficial ownership of 5.1% of Investar Holding Corp's common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has disclosed a beneficial ownership of 4.6% of Perspective Therapeutics Inc.'s common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.4% of LSI Industries Inc.'s common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 4.99% of Teekay Tankers Ltd. Class A Stock as of March 31, 2026.
NYSE
BlackRock, Inc. has reported beneficial ownership of 5.1% of Descartes Systems Group Inc.'s common stock as of March 31, 2026.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G reporting a 9.6% beneficial ownership stake in OneSpaWorld Holdings Limited.